Ketamine is the medication used for anesthesia. It delivers pain relief and sedates a person, while generally maintaining the normal functions of the heart and lungs.
Several studies have proven that ketamine can be an effective and rapid-acting medication for depression and thus may have therapeutic potential, according to the Expert Review of Neurotherapeutics journal. The U.S. Food and Drug Administration (FDA) recently approved Spravato – a nasal spray with Esketamine as its main ingredient – as antidepressant medication.
Over 300 million people globally are estimated to be affected by depression, according to the World Health Organization (WHO). Around 800,000 people die by suicide every year because of this mental health disease and it is the leading cause of death among young adults.
Click the link below to find out more: